Blueprint for an Innovation Economy in Florida Research as Economic Foundation | Page 24
EXHIBITS
EXHIB
AxoGen
ABBREVIATED TIMELINE
Pre-Com p any - R&D Predominently NIH Funded. Outcome: Key Basic Discoveries Governing Nerve Cell Regeneration
J of Neuroscience, K
CA, Muir D, et.
J of Neuroscience, J
Zuo, D Muir, et.al.
*J Cell Biology, Muir D,
Engvall E, et.al.
*J Neurobiology, Zuo
J, Muir D, et.al.
National Institute of
Health, Muir D, Grant
$750K, 5 YR
Molecluar Cell
Neuroscience, Ferguson
Exp Neurology, Zuo J
Muir D, et.al.
*J of Neuroscience, Krekoski CA,
Muir D, et.al.
National Institute of
Health, Muir D. Grant
$1.5M, 5 YR
AxoG
$700K
UF Files Patent
*J Grooms, J Engels Found
AxoGen, Lisc of UF Tech
Two Rounds, Four
$30.1M Equity
*Note, AxoGen funds many other research activites not shown here. Grant funding here is limited to those made to the principle
investigator whose licensed technology helped create the company.
22
Pre-Revenu